Bioavailability of Topically Applied Drugs, Volume Ⅱ

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 419

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmacy, University of Pisa, 56126 Pisa, Italy
Interests: pharmaceutical technology; drug delivery; in vitro and in vivo models; biopharmaceutics; formulation
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pharmacy, University of Pisa, 56126 Pisa, Italy
Interests: pharmaceutical technology; drug delivery; in vitro and in vivo models; biopharmaceutics; formulation; skin, eye, nail, buccal and vaginal mucosae
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

One of the main requisites for successful topical therapy is to achieve an optimal drug concentration at the target site in order to minimize systemic side effects and to reduce the required dose to be applied. The improvement of the bioavailability of topically applied drugs represents a great challenge for researchers, as the different structures to be addressed (i.e., skin, eye, nail, buccal and vaginal mucosa) present anatomo-physiological barriers and selective transport mechanisms.

Different drug delivery strategies have been pursued in order to provide selective tissue permeation and distribution, such as the use of new functional materials, the synthesis of new pro-drugs, and the development of nanotechnologies, also endowed with stimuli-triggered drug release properties. Moreover, the assessment of drug bioavailability with in vitro pharmacokinetic modeling is an important issue, even with the availability of suitable biological models and drug pharmacokinetic studies.

This is the second volume of the Special Issue “Bioavailability of Topically Applied Drugs”. The first volume published 7 high quality papers. For this Special Issue, we welcome original research or review articles dealing with formulation strategies to improve the bioavailability of topically applied drugs and in vitro/in vivo evaluation.

Prof. Dr. Patrizia Chetoni
Dr. Silvia Tampucci
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop